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Edited by Maurice MontalAbstract In MerT, the mercury transporter, a ﬁrst cysteine
pair, located in the ﬁrst trans-membrane helix, receives mercury
from the periplasm. Then, a second cysteine pair, housed in a
cytoplasmic loop connecting the second and the third trans-
membrane helices, is thought to transfer the metal to another
cysteine pair located in the N-terminal extension of the mercuric
reductase. We found that a 23-amino acid synthetic peptide
corresponding to the cytoplasmic loop can bind one mercury
atom per molecule and that this mercury atom can be transferred
speciﬁcally to MerAa. The solution structure of Hg-bound
ppMerT has been solved by 1H NMR spectroscopy.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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CH341. Introduction
The facultative autotrophic bacterium Ralstonia metallidu-
rans CH34 contains at least two copies of the canonic
merRTPAD operons conferring narrow-spectrum resistance to
inorganic mercury [1]. The merTPA genes encode the proteins
responsible for the periplasmic sequestration of Hg(II) (MerP),
the transport through the inner membrane of the metal into
the cytoplasm (MerT) and the reduction of inorganic mercury
to the less toxic elemental mercury (MerA, the cytosolic mer-
curic reductase) [2]. The products of the genes merR and merD
play crucial roles at the regulatory level [3,4]. MerP, MerT and
MerA are supposed to interact, at least transiently, in order to
drive mercury to the catalytic core of the reductase [5–7]. The
role of these proteins has been assessed by diverse genetic
techniques, including both random and site-directed muta-
genesis, and analysis of the corresponding phenotypes [8–13].
MerT alone has been demonstrated to be required for mercury
transport even if the uptake of Hg(II) is more eﬃcient along
with MerP [12]. Certain paired cysteines have been identiﬁed to* Corresponding author. Fax: +33-4-38-78-54-94.
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doi:10.1016/j.febslet.2004.08.041be essential for mercury transfer, while the role of other cys-
teine pairs remains unclear. MerT from R. metallidurans CH34
is homologous to that encoded by Tn501 from Pseudomonas
aeruginosa. They are predicted to contain three trans-mem-
brane helices (TM). The ﬁrst TM contains two adjacent cy-
steines essential for the transport [12,14]. Another cysteine pair
is located in the peptide lying in the cytoplasm and connecting
the second and third TM. The mutation of these cysteines in
Tn501-encoded MerT causes a reduction of mercury transport
[12,13]. In the same way, mutants of MerA, in which the two
N-terminal cysteines were converted to alanines or serines, are
still capable of mercuric reductase activity in vitro or mercury
resistance in vivo [10,11,15]. The N-terminal extension of the
mercuric reductase, called MerAa, has been structurally de-
ﬁned under the reduced and the Hg-bound forms, very recently
[16]. The role of the cysteines in mercury binding was unam-
biguously demonstrated. MerAa is a MerP analog and its role
could be to accept mercury from MerT and to transfer the
metal to the catalytic core of the reductase [2,16].
We have used a 23-amino acid synthetic peptide corre-
sponding to the cytoplasmic loop of MerT, and MerAa to
study the transfer of mercury between the transport protein
and the mercuric reductase. Our results argue in favor of a
speciﬁc role of these peptides in metal exchange between the
two proteins.2. Materials and methods
2.1. Proteins, peptide and chemicals
MerAa and MerP were overexpressed, puriﬁed and reduced as
previously described [16,17]. The 23-mer peptide (RRIYRQAAAC-
KPGEVCAIPQVRA) called ppMerT in the following and corre-
sponding to the cytoplasmic loop of MerT contains two cysteines. It
was synthesized by NeoSystems (Strasbourg, France) under the linear
form (reduced). GSH, L-cysteine and other chemicals were of the
purest grade commercially available.2.2. Mass spectrometry analysis of ppMerT and of its mercury binding
and exchange capacities
Electrospray mass spectrometry (ESI-MS) was performed using Q-
TOF Micromass spectrometer (Micromass, Manchester, UK) equip-
ped with an electrospray ion source as previously described [16,17]. A
stock solution of 1 mM ppMerT was prepared extemporaneously byation of European Biochemical Societies.
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luted to 100 lM in 50 mM Tris–HCl, pH 7.5. The peptide was then
titrated by addition of increasing amounts of HgCl2. The concentra-
tion of the mercury solution was calculated so that the added volume
for each titration was negligible. ESI-MS spectra were recorded one
minute after each addition of mercury.
For mercury transfer experiments, Hg-bound ppMerT was prepared
by a single addition of 0.8 molar equivalent of metal and then diluted
to 100 lM in 50 mM Tris–HCl, pH 7.5, containing 100 lM of one of
the following protein: reduced MerAa, reduced MerP or myoglobin.
Alternatively, the proteins were replaced with 8 mM of GSH or 200
lM of L-cysteine. After an incubation of 10 min at room temperature,
the reaction was stopped by freezing the solution in liquid nitrogen
before ESI-MS analysis.
2.3. NMR spectroscopy and structure calculation
1H NMR spectra were recorded on a Bruker Avance spectrometer
operating at 500 MHz at 298 K. Samples (1.1 mM) of the peptide (apo-
or Hg-bound form) were prepared in D2O/H2O (1/9 v/v). Water sup-
pression was achieved with the watergate pulse sequence [18,19].
TOCSY [20] spectra were collected with 70 ms mixing time, t-ROESY
[21,22] with 100 ms mixing time (3300 Hz spin-lock), and NOESY
experiments with 100, 200, 300 and 400 ms mixing times. Coupling
constants (3JNH;Ha) were measured by Soft-COSY [23] experiments.
199Hg NMR spectra were recorded on a Varian Mercury spectrometer
operating at 71.6 MHz. For that purpose, a 2.4 mM solution of Hg-2557 2757
C
D
2557 2757
A
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2550 2650 2750 2550 2650 2750
Mass (Da) Mass (Da)
Fig. 1. ESI-MS titration of ppMerT with HgCl2. (A) Synthetic linear
ppMerT, (B–D) ppMerT+0.5, 0.75 and 1 molar equivalent of HgCl2.
The mass of apo-ppMerT or Hg-bound ppMerT is reported at the head
of each panel.
Table 1
1H NMR (500 MHz) chemical shifts (d ppm) for Hg-bound ppMerT (residu
Residue HN Ha Hb
Cys10 8.27 4.41 3.30, 3.0
Lys11 8.03 4.52 1.73, 1.4
Pro12 – 4.25 2.21, 1.7
Gly13 8.67 4.09, 3.61
Glu14 7.64 4.41 2.18, 1.9
Val15 8.50 4.03 2.01
Cys16 8.32 4.55 3.34, 3.2
Ala17 8.32 4.29 1.28bound ppMerT was prepared using 91% enriched 199Hg2þ. Chemical
shift of 199Hg is reported relative to Hg(CH3)2 (0 ppm) [24].
Solution structures were calculated using the program X-PLOR 3.1
following standard reﬁnement protocols [25]. Upper and lower limits
for distance constraints were set to 15% of the H–H distances ob-
tained by integration of NOESY spectra (200 and 300 ms). Gly Ha1/
Ha2 (1.78 A), Pro Hd1/Hd2 (1.78 A), Pro Ha/Hb1 (2.36 A) and Pro
Ha/Hb2 (2.70 A) were used as references for distance calibration. U
dihedral constraints were derived from 3JHN;Ha coupling constants.
Pseudo-atom corrections were applied to non-stereospeciﬁcally as-
signed methylenes and methyl groups [26]. The S–Hg bond lengths
were set to 2.33 A, which is typical of linear bicoordinate RS–Hg–SR
complexes [27,28]. No NOE violations greater than 0.3 A and no di-
hedral angles violations greater than 5 were found.3. Results
3.1. Mercury binding capacity of ppMerT
Fig. 1 shows the reconstructed mass spectrum of ppMerT.
The mass of 2557 Da ﬁts perfectly the expected mass deduced
from the amino acid sequence of ppMerT. As ppMerT was
already reduced, it has been used directly for the binding ex-
periments. Upon the ﬁrst addition of 0.5 mercury equivalent,
one extra peak appeared with a mass diﬀerence of 200 Da with
respect to the ppMerT native mass. This corresponds to the
addition of one mercury atom. As further mercury was added,
the proportion of peptide with bound-mercury increased, while
the proportion of the apo-form decreased. Finally, a full con-
version to Hg-bound ppMerT is observed for one mercury
equivalent. As previously observed for MerP or MerAa, the
binding of the mercury is strong enough to resist the ESI-MS
conditions [16,17].
3.2. Folding of ppMerT upon mercury binding
The solution structures of the apo- and Hg-bound forms of
ppMerT were investigated by 1D and 2D 1H NMR experi-
ments (not shown). All NH resonances but one in the 1H
spectrum of apo-ppMerT (1.1 mM in H2O/D2O 9:1, pH 4.0)
were in the [7.95 ppm, 8.45 ppm] window. The t-ROESY
spectrum showed very few inter-residue correlations and the a
protons of Gly13 were not diﬀerentiated. These data account
for a fully unfolded apo-peptide. Upon addition of 1.1 eq. of
HgCl2, signiﬁcant changes appeared in the
1H NMR spectrum
(Table 1). The decrease of the pH to 2.5 and the downﬁeld shift
of both cysteines (Cys10 and Cys16) Hb protons (about 0.5
ppm) suggest a deprotonation of the sulfur groups and an
involvement of the cysteines in mercury binding. A linear co-
ordination of Hg2þ by the two cysteines was conﬁrmed by the
199Hg NMR chemical shift ()1008 ppm) of ppMerT-Hg [24].
We checked that the neighboring carboxylate of Glu14 was not
coordinated to Hg2þ by raising the pH to 5.6 with NaOH. No
change occurred in the spectrum except the up-ﬁeld shift ofes 10–17) in H2O/D2O at 298 K
Others
8
9 CH2(c): 1.36; CH2(d): 1.58; CH2(e): 2.89
8 CH2(c): 2.03, 1.90; CH2(d): 3.78,3.51
6 CH2(c): 2.38
CH2(c): 0.86
9
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A
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Concomitantly to mercury binding, the NH resonances of
residues 10–16 were strongly shifted while the others were not,
and a higher number of inter-residue NOEs were observed in
this part of the peptide, thereby suggesting the structural or-
ganization of the CKPGEVC motif. Actually, characteristic
elements of a type II b-turn structure for the KPGE sequence
were identiﬁed: a trans peptide bond for proline (d(Lys11 Ha,
Pro10 Hd)¼ 2.2 A), a cis relationship between Gly13 HN and
Pro12 Ha (2.0 A), and a relatively strong NOE cross-peak
between Glu14 HN and Pro10 Ha (3.3 A) [29]. However, all
values of 3JHN;Ha couplings in the CKPGEVC motif were in
the 6–8 Hz range except for Glu14 (8.5 Hz). Thus, although the
CKPGEVC motif folds upon mercury binding, it remains
ﬂexible. As the two extensions beyond the cysteines were not
structured upon mercury binding, only residues 9–17 were
introduced in the structure calculations. Forty NOE-derived
H–H distance constraints and one U dihedral constraint were
used for the calculations. Fifty structures were calculated using
X-PLOR 3.1 [25]. They had very similar energies and re-
sponded to the imposed constraints. A superimposition of the
20 lowest energy structures is shown in Fig. 2A. The b-turn
(residues 11–14) is relatively rigid and consequently was rather
well deﬁned with an excellent superimposition of the 20
structures in this region (backbone RMSD: 0.67 A). The other
amino acids are more mobile as expected from the NMR
analysis. The lowest energy structure depicted in Fig. 2B shows
how ppMerT forms a cycle through mercury binding by the
two cysteine sulfur atoms.
The complexation properties of ppMerT towards other
metals (Zn2þ, Cd2þ and Pb2þ) have been investigated. As for
Hg2þ, ESI-MS shows the formation of 1:1 complexes and 1H
NMR competition experiments showed that mercury quanti-
tatively displaces the other three cations (not shown), thereby
reﬂecting the speciﬁcity of ppMerT for Hg2þ.Fig. 2. Solution structure of Hg-bound ppMerT. Top panel: super-
imposition of the 20 lowest energy structures. Bottom panel: lowest
energy structure of the 9ACKPGEVCA17 sequence. The sphere rep-
resents the mercury atom and the amino acids are identiﬁed.3.3. Exchange of mercury between ppMerT and putative
partners
The initial ESI-MS spectrum of Hg-bound ppMerT used in
metal exchange experiments is shown in Fig. 3A. Hg-bound
ppMerT incubated with apo-MerAa was transformed essen-
tially to the apo-form (Fig. 3B), while Hg-bound MerAa ap-
peared along with apo-MerAa (Fig. 3E). The mass spectrum of
MerAa (Fig. 3E) showed four peaks because this peptide was
puriﬁed under two forms: with or without the initial methio-
nine [16]. These two sub-populations have a mass diﬀerence of
131 Da and the apo- or the Hg-bound forms have a mass
diﬀerence of 200 Da. In order to check the speciﬁcity of the
metal transfer, several controls were performed. First, Hg-
bound ppMerT was mixed with apo-MerP. MerP is a struc-
tural analog of MerAa and contains a similar mercury-binding
domain [16,17]. However, under these conditions, only half of
the ppMerT population lost its metal (Fig. 3C), while MerP
remained essentially under the apo-form (Fig. 3F). Second, in
the presence of 8 mM GSH, a concentration representing the
physiological concentration of reduced glutathione in bacterial
cytoplasm, a similar result was obtained, only half of ppMerT
lost its metal (Fig. 3D). The same result was also obtained by
incubating Hg-bound ppMerT with 200 lM of L-cysteine (not
shown). Third, Hg-bound ppMerT was mixed with myoglobin,
a protein without any relation with mercury binding. As a
consequence, ppMerT remained essentially under the2550 2650 2750
C
D
B
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6700 6800 6900 7000
F
77207520
MerP
7500 7620 7740
Fig. 3. Exchange of mercury between ppMerT and partners followed
by ESI-MS. The conditions of incubation and analysis of the diﬀerent
components of the system are described in Section 2. The ppMerT
panel shows (A) Hg-bound ppMerT obtained after incubation of 100
lM ppMerT with 80 lM HgCl2, (B) Hg-bound ppMerT after incu-
bation with 100 lM of MerAa, (C) 100 lM of MerP and (D) 8 mM of
GSH. The masses of apo- and Hg-bound ppMerT are indicated in Fig.
1. The ESI-MS analyses of MerAa and MerP after incubation with
Hg-bound ppMerT are depicted in panels E and F, respectively. The
exact mass expressed in Da of the diﬀerent forms of the proteins is
indicated at the head of each panel.
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shown).4. Discussion
The present study focuses on the putative exchange of
mercury between a 23-mer linear synthetic peptide mimicking
the cytoplasmic loop of MerT and the N-terminal domain of
MerA. Synthetic peptides mimicking the well-known metal-
binding motif MxCxxC have already been used to delineate the
structure or the metal selectivity of proteins such as MerP
[27,30] or Atx1 [31]. In both cases, NMR was the method of
choice. Interestingly, Opella and coworkers [32] found that a
xxCC motif was much more speciﬁc for Hg(II) than the CxxC
one. The xxCC motif found in the ﬁrst TM of MerT could
make the transport protein the central piece in selection of the
metal to be incorporated by the bacterium [32]. We found that
ppMerT is also speciﬁc for Hg(II) over the biologically rele-
vant ion Zn2þ, or other toxic cations such as Cd2þ or Pb2þ.
The binding of mercury is accompanied by the folding of
ppMerT. The coordination-induced structural organization is
favored by the presence of a proline–glycine motif in the
CKPGEVC sequence that induces a b-turn bringing closer the
two reactive cysteines. The two extensions beyond the cysteines
were found to be highly ﬂexible even in the presence of mer-
cury. Such a ﬂexibility is very unlikely in native MerT, since
these extensions are directly connected to the second and third
TM. One can thus describe the cytoplasmic loop as a pre-or-
ganized cyclic peptide rigidiﬁed by the b-turn and the ﬁxation
to the TM. Moreover, as the cytoplasm is known to provide a
reductive environment, the thiol groups would be immediately
ready for the coordination of the mercury atom.
We have also shown that mercury was easily exchangeable
between Hg-bound ppMerT and apo-MerAa. The mass
spectrometry analysis of ppMerT after mixture with apo-
MerAa suggested an almost quantitative exchange of metal
between the two peptides. It is noteworthy that, under these
conditions, the solutions did not contain additional thiols
such as the biologically relevant glutathione. This shows that
GSH is dispensable for the transfer of mercury from MerT
to MerAa, although a donor thiol ligand such as a Hg(II)-
diglutathione adduct is required to provide Hg(II) to the
catalytic core of the mercuric reductase for good reduction in
vitro [2,10]. Actually, MerAa has the perfect size and shape
[2,7,16] to play the role of such a protein dithiol Hg(II) che-
lator and could be directly involved in the transfer of Hg(II)
to the cysteines of the active center. Interestingly, we have
shown that 8 mM GSH did not cause the full demetallation of
Hg-bound ppMerT. This suggests that MerAa is exquisitely
designed to take mercury from the transporter. Even if the
N-terminal extension of MerA can be absent in certain mer-
curic reductases [33], for the large majority of these enzymes,
it is found in one or several copies. It has been hypothesized
recently that MerAa may become critical under conditions of
depletion of the cellular thiol pool and a correlation between
the number of MerAa repeats and the ability of the cell to
synthesize high concentrations of glutathione has been noted
[2]. Cells with low cellular thiol concentration have double
repeats, while cells synthesizing GSH at high concentration
have only a single repeat. Our results are in full agreement
with these hypotheses.As the transfer of mercury between ppMerT and MerAa is
fast and almost quantitative, we can conclude that the disso-
ciation constant of Hg(II) for ppMerT is higher than the Kd of
mercury for MerAa, which has been determined in the mi-
cromolar range [34]. However, it is noteworthy that MerP was
not able to fully transform Hg-bound ppMerT to apo-ppM-
erT, although it shares with MerAa similar metal-binding
domain, tri-dimensional structure and dissociation constant
for mercury [35,36]. This could reﬂect a basic thermodynamic
control of the metal exchange due to slight diﬀerences in dis-
sociation constants. However, in vivo, the metal exchange
between MerT and MerAa may be favored by a transient
electrostatic interaction between the two partners. Indeed, the
cytoplasmic loop of MerT bears several positively charged
residues (1 lysine and 4 arginines) and the metal-binding do-
main of MerAa contains an acidic residue (GMTCDSC).
These charged residues could participate in such an interaction
leading to a more productive metal exchange.
In conclusion, our data are consistent with a direct role of
the cytoplasmic loop of MerT and the N-terminal extension of
MerA in mercury exchange between the two proteins. More-
over, it is very likely that the paired cysteines found in the C-
terminal ends of MerF (two adjacent cysteines) or MerC
(Cx4C), two other mercury transport proteins [14], should have
a similar role. Interestingly, the C-terminal ends of these two
proteins are also considerably rich in lysines and arginines.References
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